CLINICAL NEWS
tell, but this moment may prove to be a pivotal one in
the assessment of MRD to assign treatment in patients
with AML,” Dr. Burke concluded.
REFERENCES
Ivey A, Hills RK, Simpson MA, et al. Assessment of Minimal residual disease in standard-risk